Hai-Liang Xin (Hailiang Xin)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Top Venues

The Journal of pharmacy and pharmacology

The American journal of Chinese medicine

Biopharmaceutics & drug disposition

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Kun Li, Yiping Jiang, Nani Wang, Liyong Lai, Shengyan Xu, Tianshuang Xia, Xiaoqiang Yue, Hai-Liang Xin
Traditional Chinese Medicine in Osteoporosis Intervention and the Related Regulatory Mechanism of Gut Microbiome. The American journal of Chinese medicine (2023)
Xiao-Lei Sun, Jia-Bao Zhang, Yun-Xiang Guo, Tian-Shuang Xia, Ling-Chuan Xu, Khalid Rahmand, Guo-Ping Wang, Xiao-Jin Li, Ting Han, Na-Ni Wang, Hai-Liang Xin
Xanthohumol ameliorates memory impairment and reduces the deposition of β-amyloid in APP/PS1 mice via regulating the mTOR/LC3II and Bax/Bcl-2 signalling pathways. The Journal of pharmacy and pharmacology 73 (9) (2022)
Tianshuang Xia, Xiaoyan Liu, Nani Wang, Yiping Jiang, Huanhuan Bai, Weifan Xu, Kunmiao Feng, Ting Han, Hai-Liang Xin
PI3K/AKT/Nrf2 signalling pathway is involved in the ameliorative effects of xanthohumol on amyloid β-induced oxidative damage and bone loss. The Journal of pharmacy and pharmacology 74 (7) (2022)
Huan-Huan Bai, Tian-Shuang Xia, Yi-Ping Jiang, Wu-Mu Xu, Ping-Cui Xu, Na-Ni Wang, Xiao-Jun Gou, Hai-Liang Xin
Absorption, metabolism, and pharmacokinetic profile of xanthohumol in rats as determined via UPLC-MS/MS. Biopharmaceutics & drug disposition 43 (1) (2021)
Weiyue Zhang, Xiaoyan Liu, Yiping Jiang, Nani Wang, Feng Li, Hai-Liang Xin
6-Gingerol Attenuates Ischemia-Reperfusion-Induced Cell Apoptosis in Human AC16 Cardiomyocytes through HMGB2-JNK1/2-NF-κB Pathway. Evidence-based complementary and alternative medicine : eCAM 2019 (2019)